| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |